IGF2BP1 and neoplasm: The expected similarities and conservation of SRF’s and IGF2BP1’s roles in modulating tumor cell properties suggested that the post-transcriptional regulator IGF2BP1 synergizes with the transcriptional regulator SRF in promoting an ‘aggressive’ tumor cell phenotype.